About StemSource
StemSource is a company based in Thousand Oaks (United States) founded in 2000 was acquired by Bionity in October 2002. StemSource operates in a competitive market with competitors including StemCyte, China Cord Blood, Generate, LaCell and Forever Labs, among others.
- Headquarter Thousand Oaks, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Bionity
(Oct 09, 2002)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of StemSource
Detailed funding history for StemSource
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in StemSource
StemSource has secured backing from 1 investor. Prominent investors backing the company include bionity.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Information on life sciences, biotechnology, and pharma is offered online.
|
Locked | Locked | Locked |
Investor details for StemSource
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by StemSource
Investment portfolio details for StemSource
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - StemSource
Detailed financials for StemSource
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stemsource Comparisons
Peer comparison for StemSource
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of StemSource
StemSource operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StemCyte, China Cord Blood, Generate, LaCell and Forever Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Umbilical cord blood stem cell transplantation and therapeutic products company
|
|
| Locked | Locked | Locked |
Biobanking services for umbilical cord blood stem cells are provided.
|
|
| Locked | Locked | Locked |
Provider of services for the storage of stem cells
|
|
| Locked | Locked | Locked |
Stem Cell Production
|
|
| Locked | Locked | Locked |
Stem cells are stored and preserved for future therapeutic applications.
|
|
| Locked | Locked | Locked |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
Detailed competitors of StemSource
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stemsource
Complete news archive for StemSource
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StemSource
StemSource was founded in 2000.
StemSource is headquartered in Thousand Oaks, United States. It is registered at Thousand Oaks, California, United States.
Marc Hedrick is the current CEO of StemSource.
StemSource was established in 2000 in Thousand Oaks, United States, within the biobanking and regenerative medicine sector. Operations center on the collection and preservation of stem and regenerative cells from adipose tissue, recognized as a primary source. A minor liposuction procedure is utilized to harvest these cells, enabling their storage for potential therapeutic uses in medical applications.
StemSource's top competitors include StemCyte, Forever Labs and China Cord Blood.
StemSource has 1 investor. Key investors include bionity.com.